SCHEMBL4040892

SCHEMBL4040892

O=P(O)(OCCl)OCc1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.81
SRC P12931 1/20 0.53
CETP P11597 3/20 0.49
AKR1C3 P42330 1/20 0.49
PDPK1 O15530 2/20 0.45
MTOR P42345 1/20 0.45
ALPG P10696 1/20 0.45
PTK2B Q14289 1/20 0.45
ALDH1A1 P00352 2/20 0.44
FOLH1 Q04609 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27908642 0.90 TSHR (1.00) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL51316 0.90 TSHR (1.00) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL28032525 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
Ammonia Solution, Strong SCHEMBL7268743 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL28264490 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL4219700 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
Hydrochloric Acid SCHEMBL10722992 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL9446520 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
SCHEMBL11756554 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1
Phosphoric Acid SCHEMBL27741297 0.88 TSHR (0.96) TSHRSRCCETPAKR1C3PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931716-B1 PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS NOVARTIS AG (CH) 2016-11-02 EP disclosed
WO-2014093606-A1 PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS NOVARTIS AG (CH) 2014-06-19 WO disclosed
EP-2079699-A1 QUINOLINE DERIVATIVES Envivo Pharmaceuticals, Inc. (US) 2009-07-22 EP disclosed
WO-2008014602-A1 QUINOLINE DERIVATIVES ENVIVO PHARMACEUTICALS, INC. (US) 2008-02-07 WO disclosed